Certolizumab Pegol is Effective at Maintaining Response and Remission in Patients With Fistulising Crohn's Disease: 3-Year Results From the PRECiSE 3 Study

被引：0
|
作者：
Schreiber, Stefan
Lawrance, Ian C.
Thomsen, Ole O.
Hanauer, Stephen B.
Bloomfield, Ralph
Sandborn, William J.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1035
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [1] Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 Study
    Rubin, David
    Randall, Charles
    Coarse, Jason
    Kosutic, Gordana
    Spearman, Marshall
    Ambarkhane, Sumeet
    Jojic, Njegica
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S508 - S509
  • [2] Disease Location as a Risk Determinant for Maintenance of Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Results of Analyses From the PRECiSE 3 Study
    Schreiber, Stefan
    Randall, Charles
    Dubinsky, Marla
    Kosutic, Gordana
    Pierre-Louis, Bosny
    Spearman, Marshall
    Sandborn, William
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S513 - S513
  • [3] Long-term remission with certolizumab pegol in Crohn's disease over 3.5 years: results from the PRECiSE 3 study
    Lichtenstein, G.
    Thomsen, O.
    Schreiber, S.
    Lawrance, I
    Hanauer, S.
    Bloomfield, R.
    Sandborn, W.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S12 - S13
  • [4] Long-Term Outcomes of Certolizumab Pegol for Crohn's Disease: 7 Year Results From the PRECiSE 3 Study
    Sandborn, William
    Lee, Scott D.
    Randall, Charles W.
    Gutierrez, Alexandra
    Schwartz, David A.
    Ambarkhane, Sumeet
    Kayhan, Cem
    Pierre-Louis, Bosny
    Kosutic, Gordana
    Schreiber, Stefan
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S588 - S589
  • [5] Long-term Remission with Certolizumab Pegol in Crohn's Disease over 3.5 Years: Results from the PRECiSE 3 Study
    Lichtenstein, Gary
    Thomsen, Ole
    Schreiber, Stefan
    Lawrance, Ian
    Hanauer, Stephen
    Bloomfield, Ralph
    Sandborn, William
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S450 - S450
  • [6] Serum Albumin as a Predictor of Long-Term Response and Remission With Certolizumab Pegol for Crohn's Disease: Results From 7-Year Data From the PRECiSE 3 Study
    Sandborn, William
    Macrae, Finlay
    Lawrance, Ian
    Sen, David
    Abbas, Sarah
    Douglas, Kevin
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S512 - S512
  • [7] Long-term maintenance of remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation: 3-year results from the PRECiSE 4 study
    Sandborn, W.
    Schreiber, S.
    Hanauer, S.
    Colombel, J.
    Bloomfield, R.
    Lichtenstein, G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S14 - S14
  • [8] Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study
    Sandborn, William
    Schreiber, Stefan
    Hanauer, Stephen
    Colombel, Jean-Frederick
    Bloomfield, Ralph
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S448 - S448
  • [9] Predictors of Response and Remission to Certolizumab Pegol in Patients With Crohn's Disease: Data From the WELCOME Study
    Sandborn, William J.
    Abreu, Maria T.
    D'Haens, Geert R.
    Colombel, Jean-Frederic
    Vermeire, Severine
    Mitchev, Krassimir
    Ernault, Etienne
    Fedorak, Richard N.
    Spehlmann, Martina
    Wolf, Douglas C.
    Lee, Scott D.
    Rutgeerts, Paul J.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
  • [10] Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study
    Sandborn, William J.
    Schreiber, Stefan
    Hanauer, Stephen B.
    Colombel, Jean-Frederic
    Bloomfield, Ralph
    Lichtenstein, Gary R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (08) : 696 - 702
12345